Xencor Inc.

Xencor Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$2.48 B
Shares Outstanding
56.35 M
Public Float
55.56 M


111 West Lemon Avenue
Monrovia California 91016
United States
Employees -
Website http://www.xencor.com
Updated 07/08/2019
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I.


View All

Bassil I. Dahiyat
President, Chief Executive Officer & Director
Richard J. Ranieri
Independent Director